
The STERI 700 is a wide-chamber-based product developed to meet the demand for sterilizing large medical devices. It is approximately four times wider than the company’s existing small sterilizers and is designed to accommodate long or bulky medical devices. With a 30L-class capacity, it is capable of handling medical devices that were previously processed mainly by larger sterilizers of 50L or 100L class and above.
Following the completion of product development and domestic regulatory approval procedures, Plasmapp Co., Ltd. has also conducted performance tests with medical institutions. In the ophthalmology field, the company is conducting product tests with Alcon, a global ophthalmic medical device company, to evaluate the product’s applicability. Based on these results, the company plans to expand its existing dental customer base to various medical specialties.
The company is also undergoing certification procedures for overseas expansion. Plasmapp Co., Ltd. is pursuing U.S. Food and Drug Administration (FDA) 510(k) and European CE certifications, with the goal of obtaining approval in the first half of next year. The strategy involves proceeding with certification procedures in stages according to each country’s regulatory requirements to secure the foundation necessary for entering overseas markets and to expand opportunities to supply products to global medical institutions in the future.
Lee Yoon-cheol, CEO of Plasmapp Co., Ltd., stated, “The STERI 700 is a key product that will enable us to expand our sterilization business—which has traditionally focused on dentistry—into various medical specialties.” He added, “We are actively creating opportunities to enter new markets, such as by conducting product testing with a global U.S.-based ophthalmic medical device supplier.”